Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA kazia therapeutics limited

0.00%

8.0¢

So then why does the Drug Monitoring Committee want more...

First 3 Last

Share
Profile

Follow
newbbee

203 Posts.

17

19/06/18

23:20

Post #: 33812238
Share

Originally posted by harvett ↑

I don't think they had a tough time recruiting patient. There was only nine dose chorts and because they run into...well it seems like no real toxicity issues, they only needed 9 patients, to run up to the max 20mg dose. After that it would seem they lost some patients with death or none evable reasons. Read between the lines. Low toxicity and patients going the whole 8 cycles or 6 months. In other words they had a great start and only needed the lower numbers but at the end those NE reduced the numbers down to 5 which is meaningless and thus the need for more again. Yes I think that stuffed up but for a good reason.

Expand

So then why does the Drug Monitoring Committee want more patients recruited?

KZA Price at posting: 60.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

AII

Inside the depths of Panasqueira: A legacy carved in rock

Trump just dropped a 200% tariff bomb. Here's how to cash in

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

So then why does the Drug Monitoring Committee want more...

Top Stories

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Inside the depths of Panasqueira: A legacy carved in rock

Trump just dropped a 200% tariff bomb. Here's how to cash in

Featured News